Literature DB >> 16120814

Signal transduction for proteinase-activated receptor-2-triggered prostaglandin E2 formation in human lung epithelial cells.

Naoyuki Kawao1, Mami Nagataki, Keita Nagasawa, Satoko Kubo, Kelly Cushing, Tetsuyuki Wada, Fumiko Sekiguchi, Seiji Ichida, Morley D Hollenberg, Wallace K MacNaughton, Hiroyuki Nishikawa, Atsufumi Kawabata.   

Abstract

We investigated proteinase-activated receptor-2 (PAR(2))-triggered signal transduction pathways causing increased prostaglandin E(2) (PGE(2)) formation in human lung-derived A549 epithelial cells. The PAR(2) agonist, SLIGRL-NH(2) (Ser-Leu-Ile-Gly-Arg-Leu-amide), evoked immediate cytosolic Ca(2+) mobilization and delayed (0.5-3 h) PGE(2) formation. The PAR(2)-triggered PGE(2) formation was attenuated by inhibition of the following signal pathway enzymes: cyclooxygenases 1 and 2 (COX-1 and COX-2, respectively), cytosolic Ca(2+)-dependent phospholipase A(2) (cPLA(2)), the mitogen-activated protein kinases (MAPKs), mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) and p38 MAPK, Src family tyrosine kinase, epidermal growth factor (EGF) receptor tyrosine kinase (EGFRK), and protein kinase C (PKC), but not by inhibition of matrix metalloproteinases. SLIGRL-NH(2) caused prompt (5 min) and transient ERK phosphorylation, blocked in part by inhibitors of PKC and tyrosine kinases but not by an EGFRK inhibitor. SLIGRL-NH(2) also evoked a relatively delayed (15 min) and persistent (30 min) phosphorylation of p38 MAPK, blocked by inhibitors of Src and EGFRK but not by inhibitors of COX-1 or COX-2. SLIGRL-NH(2) elicited a Src inhibitor-blocked prompt (5 min) and transient phosphorylation of the EGFRK. SLIGRL-NH(2) up-regulated COX-2 protein and/or mRNA levels that were blocked by inhibition of p38 MAPK, EGFRK, Src, and COX-2 but not MEK-ERK. SLIGRL-NH(2) also caused COX-1-dependent up-regulation of microsomal PGE synthase-1 (mPGES-1). We conclude that PAR(2)-triggered PGE(2) formation in A549 cells involves a coordinated up-regulation of COX-2 and mPGES-1 involving cPLA(2), increased cytosolic Ca(2+), PKC, Src, MEK-ERK, p38 MAPK, Src-mediated EGF receptor trans-activation, and also metabolic products of both COX-1 and COX-2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120814     DOI: 10.1124/jpet.105.089490

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

1.  Selective eicosanoid-generating capacity of cytoplasmic phospholipase A2 in Pseudomonas aeruginosa-infected epithelial cells.

Authors:  Bryan P Hurley; Waheed Pirzai; Karen L Mumy; Karsten Gronert; Beth A McCormick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

2.  Proteinase-activated receptors 1 and 2 and the regulation of porcine coronary artery contractility: a role for distinct tyrosine kinase pathways.

Authors:  Mahmoud El-Daly; Mahmoud Saifeddine; Koichiro Mihara; Rithwik Ramachandran; Christopher R Triggle; Morley D Hollenberg
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 3.  Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling.

Authors:  P J Little; M D Hollenberg; D Kamato; W Thomas; J Chen; T Wang; W Zheng; N Osman
Journal:  Br J Pharmacol       Date:  2016-02-16       Impact factor: 8.739

4.  PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes.

Authors:  Peter Tzu-Yu Chien; Hsi-Lung Hsieh; Pei-Ling Chi; Chuen-Mao Yang
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

5.  β-Arrestin-2 mediates the proinflammatory effects of proteinase-activated receptor-2 in the airway.

Authors:  Heddie L Nichols; Mahmoud Saffeddine; Barbara S Theriot; Akhil Hegde; Daniel Polley; Tamer El-Mays; Harissios Vliagoftis; Morley D Hollenberg; Emma H Wilson; Julia K L Walker; Kathryn A DeFea
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-25       Impact factor: 11.205

Review 6.  Gastrointestinal roles for proteinase-activated receptors in health and disease.

Authors:  A Kawabata; M Matsunami; F Sekiguchi
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

7.  Proteinase-activated receptor 2 stimulates Na,K-ATPase and sodium reabsorption in native kidney epithelium.

Authors:  Luciana Morla; Gilles Crambert; David Mordasini; Guillaume Favre; Alain Doucet; Martine Imbert-Teboul
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

Review 8.  Protease-activated receptors and prostaglandins in inflammatory lung disease.

Authors:  Terence Peters; Peter J Henry
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

9.  RGS4 promotes allergen- and aspirin-associated airway hyperresponsiveness by inhibiting PGE2 biosynthesis.

Authors:  Gordon S Wong; Jamie L Redes; Nariman Balenga; Morgan McCullough; Nathalie Fuentes; Ameya Gokhale; Cynthia Koziol-White; Joseph A Jude; Laura A Madigan; Eunice C Chan; William H Jester; Sabrina Biardel; Nicolas Flamand; Reynold A Panettieri; Kirk M Druey
Journal:  J Allergy Clin Immunol       Date:  2020-03-19       Impact factor: 10.793

10.  Protease-Activated Receptor-2 Up-Regulates Transient Receptor Potential Vanilloid 4 Function in Mouse Esophageal Keratinocyte.

Authors:  Nobuhiro Suzuki; Hiroshi Mihara; Hirofumi Nishizono; Makoto Tominaga; Toshiro Sugiyama
Journal:  Dig Dis Sci       Date:  2015-08-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.